DE | EN

Dr.rer.nat. Catharina Groß

Current affiliations

Department for Neurology

Publications

Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response. Teschner VE; Fleck AK; Walter C; Schwarze AS; Eschborn M; Wirth T; Steinberg OV; Schulte-Mecklenbeck A; Lu IN; Herrera-Rivero M; Janoschka C; Lünemann JD; Schwab N; Meyer Zu Hörste G; Varghese J; Gross CC; Pul R; Kleinschnitz C; Mader S; Meinl E; Stoll M; Wiendl H; Klotz L (2023) In: Therapeutic Advances in Neurological Disorders, 16 Type of Publication: Research article (journal)
Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry Heming, Michael; Mueller-Miny, Louisa; Rolfes, Leoni; Schulte-Mecklenbeck, Andreas; Brix, Tobias J.; Varghese, Julian; Pawlitzki, Marc; Pavenstaedt, Hermann; Kriegel, Martin A.; Gross, Catharina C.; Wiendl, Heinz; Meyer zu Hoerste, Gerd (2023) In: Journal of Neuroinflammation, 20(1) Type of Publication: Research article (journal)
Antibody response to herpes simplex virus-1 is increased in autoimmune encephalitis. Chuquisana O, Strippel C, Gross CC, Melzer N, Kühn J, Kovac S, Wiendl H, Lünemann JD (2022) In: European Journal of Immunology, 52(7) Type of Publication: Research article (journal)
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses. Pfeuffer S, Rolfes L, Wirth T, Steffen F, Pawlitzki M, Schulte-Mecklenbeck A, Gross CC, Brand M, Bittner S, Ruck T, Klotz L, Wiendl H, Meuth SG (2022) In: Journal of Neuroinflammation, 19(1) Type of Publication: Research article (journal)
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients. Trümpelmann S, Schulte-Mecklenbeck A, Steinberg OV, Wirth T, Fobker M, Lohmann L, Lünemann JD, Wiendl H, Gross CC, Klotz L (2022) In: Clinical and Translational Science, 15(7) Type of Publication: Research article (journal)

Show all publications

Projects

CRC TRR 128 A09: Analysis and therapeutic modifications of innate immune regulatory networks in controlling T-cell activation in MS Duration: 01/01/2021 - 30/06/2024 \| 3rd Funding period Funded by: DFG - Collaborative Research Centre Type of project: Subproject in DFG-joint project hosted at University of Münster
Neuronal self-renewal by antigen-specific Tolerization in Mutiple Sclerosis reinstalling the Ballance between Inflammation and Regeneration (RESTORE) Duration: 01/01/2018 - 31/12/2023 Funded by: EC H2020 - Research and innovation actions Type of project: EU-project hosted outside University of Münster
Susac syndrome (SuS) as a paradigm of a CD8 T-cell mediated endotheliopathy Duration: 01/11/2017 - 30/10/2020 Funded by: DFG - Individual Grants Programme Type of project: Individual project
CRC TRR 128 A09: Analysis and therapeutic modifications of innate immune regulatory networks in controlling T-cell activation in MS Duration: 01/07/2016 - 31/12/2020 \| 2nd Funding period Funded by: DFG - Collaborative Research Centre Type of project: Subproject in DFG-joint project hosted at University of Münster
SFB128A09Analysis and therapeutic modification of innate immune regulatory networks in controlling T-cell responses in multiple sclerosis (SFB/CRC-TR 128) Duration: 01/07/2016 - 30/06/2020 Type of project: Own resources project

Show all projects

Talks

IL-2 receptor Modulation restores impaired NK-mediated regulation of T-cell activity in multiple sclerosis Gross, Catharina (11/03/2017) Natural Killer Cell Symposium, Düsseldorf Type of talk: scientific talk
Immunphänotypisierung in der DD der entzündlichen Erkrankungen. DGLN-Symposium: Fallstricke in der Liquordiagnostik: von Grundlagen bis Raritäten Gross, Catharina (18/03/2016) 60. Jahrestagung der Deutschen Gesellschaft für Klinische Neurophysiologie und Funktionelle Bildgebung, Düsseldorf, Deutschland Type of talk: practical talk